SUMMARY Hemodynamic parameters were studied before and after rapid dextran infusion in 34 men including 17 patients with sustained essential hypertension and 17 normotensive controls. In both groups of patients, dextran infusion induced a significant increase (p < 0.001) in central venous pressure (CVP), cardiac output (CO), and stroke rolume. The percent change in stroke volume was significantly higher in hypertensives (p < 0.001) than in controls. Three indices of volume expansion were calculated: 1) the ratio between the change in CO and the change in volume, which was significantly higher in hypertensives (p < 0.025), 2) the ratio between the change in CO and the change in CVP, which was similar in both groups, and 3) the ratio between the change in volume and the change in CVP, which was significantly reduced in hypertensives (p < 0.001). In the overall population, the latter ratio was negatively correlated with the change in CO (or in 4 The explanation for this volume-flow correlation is considered to be very simple: increased blood volume causes elevated venous pressure, and consequently increases venous return and CO. 8 This is supported by the observation that increased venous pressure coincides with increased volume and flow in several of the experimental models studied.
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1~l " However, such a simple relationship between fluid volumes and CO has not been observed in man.
Usually, normal or increased values of CO are associated with normal or decreased values of intravascular volume. 7 In a previous study, 8 we showed that, in basal conditions, a strong positive relationship between blood volume and CO is found in human essential hypertensives but not in normotensives. This observation raised several problems. First, the result was obtained from the investigation of a wide range of subjects, by means of a new type of statistical evaluation, the smoothing technique. 8 Such a methodology requires an experimental validation. Second, the cause of the close relationship between volume and flow in hypertensives was not explained. Changed performance of the heart might be involved. Reduced effective compliance of the total vascular bed has recently been shown in essential hypertension* 1 10 and could also modulate the volume-flow relationship.
In the present investigation, volume expansion by rapid dextran infusion has been performed in hypertensive patients in comparison with normotensive controls. With this methodology, the relationship between CO and blood volume has been studied in basal conditions and after volume changes. An 616 HYPERTENSION VOL 1, NO 6, NOVEMBER-DECEMBER 1979 attempt has been made to determine the contribution of cardiac and vascular factors in the characteristics of the volume-flow relationship.
Material and Methods

Patients
The study group consisted of 34 men: 17 normotensive controls and 17 sustained essential hypertensives. All were untreated or had discontinued their therapy at least 4 weeks before the study. They were hospitalized for 6 days and placed on a l 10 mEq/day sodium diet.
The subjects were considered to be normotensive controls if the reason for their admission was not a cardiovascular disease, and if after clinical and extensive laboratory investigations, they were strictly normal. Sustained hypertensives had a diastolic pressure constantly equal to or above 90 mm Hg on the third day of hospitalization. Extensive investigations included determination of blood and urinary electrolytes, urinary catecholamine levels, endogenous creatinine clearance, and timed intravenous urography. The 17 hypertensive subjects were listed as having essential hypertension. In all cases, the duration of hypertension was less than 3 years. Funduscopy showed neither hemorrhages, exudates, nor papilledema. Mean creatinine clearance for the overall population was 130 f 5 ml/min/1.73 mZ ( f 1 SEM). All hypertensive patients had a normal chest roentgenogram. Eleven patients had a normal electrocardiogram and six had only a left atrial abnormality, according to the criteria described by Frohlich et al." No patient had clinical renal, cardiac, or neurological involvement. Clinical characteristics did not differ between the two groups (table 1) .
The protocol was approved by the Institut National de la SantC et de la Recherche MCdicale (INSERM). Consent was obtained from the patients after a detailed description of the procedure.
Central Hemodynamics
On the third day of hospitalization, hemodynamic studies were performed after the patients had fasted With the subject in the supine position, CO was measured at least three times, using Waters' cuvette and densitometer as previously described.12 Indocyanine green (5 mg) was introduced into the central venous catheter and flushed into the circulation in less than 0.5 seconds. With a constant rate pump, blood was withdrawn from the arterial catheter through the densitometer. Blood was reinfused. The system was calibrated before each determination. Curves were measured planimetrically. Cardiac output was expressed in ml/min/mz after correction was made for body surface area. Arterial pressure and CVP were recorded with a Siemens apparatus. Cardiopulmonary blood volume (CPBV) was defined as the volume between the right atrium and the tip of the arterial catheter. It was calculated by the Stewart Hamilton method as follows: CPBV (ml/kg) = CO (ml/sec/kg) X MTT, where MTT is the mean transit time in seconds from the right atrium to the tip of the arterial catheter. The correction for the sampling system was subtracted from the observed time in calculating MTT.lZ Prior to the hemodynamic study, total blood volume (TBV) and total plasma volume were measured by the isotopic dilution method, using radioiodinated albumin, as previously described.lZ After withdrawal of a control sample, 3 pCi were injected. After 10 minutes, a single sample was taken for counting and volume estimations. In 20 of the 34 patients, several consecutive blood samples were taken and activity was plotted against time. The volume was calculated from the extrapolated activity at zero time. The volume was lower than that obtained from the single 10-minute sample but the difference (5 f 3%) was not significant. So, the determination with the single 10-minute sample was used as an estimation of intravascular volume in all patients. Blood volume was expressed in ml/kg. Mean hematocrit was 44 f 1 vol % in normotensive controls and 45 f 1 vol % in hypertensive subjects.
Peripheral venous compliance was estimated by plethysmography applied to the right leg. Leg volume was measured with a mercury strain gauge, and the venous distensibility was determined according to the method of Wood and Eckstein. 13 The cuff pressure was increased in steps of 1-2 mm Hg until the volume started to increase. The pressure just below that value was considered as the zero level of effective venous pressure. The cuff pressure was then increased con-secutively to 5, 10, 15, 20 and 25 mm Hg above the zero level. At each increase, pressure was kept constant until the leg volume reached its maximum value. The plateau was then recorded. In each patient, the volume-pressure relationship was calculated and the slope of the curve -the venous compliance coefficient -was expressed in ml/mm Hg/100 g tissue.
Blood Volume Expansion
Dextran was used for the blood volume expansion. To minimize secondary effects due to capillary filtration and delayed compliance, the study was carried out in the shortest possible time. 1 * Within a 4-minute period, 500 ml of 6% dextran solution were infused using a Sogreath MP 66 pump. Cardiac and peripheral hemodynamics were performed before and immediately after the infusion. In nine normotensive and nine hypertensive patients, blood volume was measured before and after volume expansion, using radioiodinated albumin. At the second determination, 6 fiCl of radioiodinated albumin were used for injection. The increases in blood volume were nearly the same in the two groups (528 ± 34 ml and 496 ± 21 ml, respectively). Central venous pressure was continuously recorded during expansion and plotted against the volume changes. The pressure-volume relationship was practically linear and the reproducibility was 6.3%, as previously described."
The linearity of the relationships between blood volume and CO, and CO and CVP, was verified as follows: in addition to the 34 patients studied, CO and CVP were measured before, during and after dextran infusion in three normotensive and four hypertensive patients. Cardiac output was determined with a No. 7 Swan-Ganz pulmonary artery thermistor catheter which was positioned under fluoroscopic control on the pulmonary artery. With this methodology, serial determinations of CO enabled the linearity of the system to be established ( fig. 1A ).
Since the system was linear, three indices of volume expansion could be calculated from the determinations of hemodynamic parameters at the beginning and the end of dextran infusion:
1. ACO/ATBV (/min) represents the ratio between the change in CO (ml/min) and the change in blood volume (ml) during expansion. This ratio corresponds to the slope of the relationship between CO and blood volume.
2. ACO/ACVP (ml/min/mm Hg) represents the ratio between the change in CO and the change in CVP during expansion. As shown in figure IB, this ratio corresponds to the slope of the relationship between CO and CVP and is used as an index of cardiac performance. 
Systolic Time Intervals
Prior to the hemodynamic study, systolic time intervals were measured from simultaneous recordings of the electrocardiogram, phonocardiogram, and carotid arterial pulse using a multichannel system, as previously described."' 17 Since mean heart rate was the same in hypertensive subjects and normotensive controls, systolic time intervals were not corrected for heart rate (table 2) .
Statistical analysis by classical methods (differences of means, paired t test, correlations, stepwise regressions) was performed on a HP 9815 A calculator.
Results
Hemodynamic Effects of Dextran Infusion
Basal hemodynamic parameters are indicated in table 3. In comparison with normotensive controls, hypertensives had similar values for cardiac index, stroke index, heart rate, CVP, right diastolic end ventricular pressure, and a significant increase in total peripheral resistance (p < 0.001). Absolute values of total and cardiopulmonary blood volumes (ml) were the same in the two groups of patients. Weightnormalized blood volume was significantly reduced in hypertensives (67 ± 2 vs 81 ± 2 ml/kg; p < 0.001).
Hemodynamic changes after volume expansion (table 3) included in both groups: 1) no significant change in blood pressure and heart rate; and 2) significant increases in CVP, cardiac index and stroke index (p < 0.001). After expansion, CVP was significantly higher in hypertensives than in normotensives (p < 0.05). The change in cardiopulmonary blood volume was significantly higher in hypertensives than in normotensives (144 ± 15 vs 102 ±9ml;p < 0.02). Figure 2 indicates that the same amount of dextran induced a higher increase in cardiac index and stroke index (p < 0.01) in hypertensives than in normotensives. The ratio between the change in CO and the change in cardiopulmonary blood volume was similar in both groups (11.2 ± 0.7 and 11.3 ± 0.7).
Basal peripheral compliance was lower in hypertensive than in normotensive subjects (6.5 ± 0.5 vs 9 ±0.3 ml/mm Hg/100 g tissue; p < 0.001). No significant changes for hypertensives and normotensives were observed after dextran infusion (1.4 ± 5% and 1.5 ± 3%, respectively).
Relationship Between Cardiac Output and Total Blood Volume Table 4 shows the correlation coefficients of the relationship between CO and blood volume in normotensive controls and in hypertensives. Before expansion, the relationship was significant in hypertensives (p < 0.001) and not in normotensive controls. Similar observations were made after expansion.
The results become obvious when, in each group, all the points of the relationship (before expansion plus after expansion) are plotted together (fig. 3) . The cor- 
. Relationship between cardiac output and central venous pressure (cardiac function curve) during volume expansion in three normotensive and four hypertensive patients. Figure IA indicates that the relationship was linear during the experiment. Figure IB shows that the slope of the cardiac function curve calculated from figure IA is equal to the approximated slope calculated from the ACO/ACVP ratio. ACO represents the change in cardiac output and ACVP the change in central venous pressure calculated from the determinations of hemodynamic parameters at the beginning and the end of dextran infusion.
relation coefficient is 0.60 in normotensive controls (p<Q.Ol) and 0.75 in hypertensives (p < 0.001). However, in comparison with the normotensive curve, the hypertensive curve is characterized by a steeper slope (2.16 ± 0.39 vs 0.97 ± 0.26; p < 0.01) with no significant difference in the intercept.
Indices of Volume Expansion
Indices of volume expansion are indicated in table 5. In comparison with normotensive controls, the ACO/ATBV ratio of hypertensives was increased (p < 0.025), while the ACO/ACVP ratio was quite similar. The ATBV/ACVP ratio was significantly reduced (p < 0.001) and was correlated positively with The changes in CO and in stroke volume were negatively correlated with the ATBV/ACVP ratio (r = -0.65 and -0.75; p < 0.001) ( fig. 5 ). These changes were not related to systolic time intervals. For instance, the correlation coefficients of the change in stroke volume with pre-ejection period (PEP) was +0.26, with left ventricular ejection time (LVET) was -0.12, and with PEP/LVET was 0.26.
Discussion
In the present investigation, rapid dextran infusion was performed in patients with essential hypertension and compared with normotensive controls. As previously shown, 9 ' 10 ' u the hemodynamic consequences represent a volume effect rather than a response to dextran per se. Both groups of patients had the same basal value of blood volume (ml) and received the same amount of dextran. At the end of volume expansion, hypertensives had a more elevated CVP, with a higher increase in stroke volume and CO. Similar tendencies have been observed in previous reports, 18 ' 19 but the observed changes were less significant. The reasons for this discrepancy can be easily explained. In earlier studies, dextran infusion was performed over a long-term period, enabling delayed compliance and reflex adjustments to occur. In our = central venous pressure; RVEDP heart rate; TPR = total peripheral report, volume expansion was performed during the shortest time possible to minimize the role of stressrelaxation and reflexes. The volume of 500 ml was chosen because, as long as the blood expansion does not exceed 10% of the estimated blood volume, the peripheral capacitance vessels behave passively. 20 In addition, no significant changes in heart and peripheral venous tone were observed in either group of patients. Thus, the observed hemodynamic variations depended mainly on the mechanical properties of the system, i.e. the cardiac pump and the distensibility of the vascular compartment. The present data confirm our previous observations concerning the relationship between CO and blood volume in normotensive and hypertensive patients.' A significant correlation was observed in hypertensives, but not in normotensives. This was true both in basal conditions and after volume expansion. When the overall points of the investigation were plotted together, the results became obvious: the volume-flow curve was significantly steeper in hypertensives than in normotensives. Moreover, the use of volume expansion provided the possibility to determine an index of the volume-flow connection in each individual patient. This index was the ACO/ATBV ratio, which was elevated in hypertensives. Since normotensives and hypertensives received the same amount of dextran, the ACO value (or the change in stroke volume) also constituted an index of the relationship between CO and blood volume in individuals. Thus, the problem is to explain the mechanism of the cardiac hyperresponsiveness to acute volume expansion in hypertensive patients.
CHANGE(X)
During volume expansion, hypertensives had a greater elevation in CVP than normotensives. In contrast, the variations in blood pressure and total peripheral resistance were nearly the same in normotensive and hypertensive patients. Thus, the changes in right atrial pressure following loading in hypertensives could be mainly caused by two diffeient factors: 1) the compliance of the peripheral vascular system, and 2) the ability of the heart to respond to the increased volume. The latter point is discussed below.
In the present study, normotensives and hypertensives had the same basal values of CO and CVP. In addition, the ACO/ACVP values were identical in the two groups of patients. Thus, within the limits of the investigation, hypertensive and normotensive subjects had the same cardiac output-central venous pressure curves.
-
15 Two other observations confirm this result: 1) the change in cardiopulmonary blood volume was significantly higher in hypertensives, and 2) systolic time intervals were similar in the two groups and were not correlated with ATBV/ACVP in hypertensives. However, left ventricular filling pressure and volume were not directly measured in the present study. Thus, a subtle alteration of cardiac compliance in hypertensives cannot be excluded. Since cardiac hypertrophy is a characteristic of sustained hypertensives, 11 ' " the problem is not really to affirm decreased cardiac compliance in these patients, but rather to evaluate its quantitative contribution to the decreased ATBV/ACVP ratio. As previously shown by others, "• " the normal value of left ventricular compliance is about 5.6 ml/mm Hg. Thus, a decreased left ventricular compliance cannot explain the 30 ml/mm Hg decrease in the ATBV/ACVP ratio observed in hypertensives (see table 5 ). Furthermore, if the reduced compliance was mainly due to a decreased compliance of ventricle, a positive or a lack of correlation would be expected between CO and effective compliance. Since the two parameters were negatively correlated, 9 -10 the result minimizes the contribution of the heart in the explanation of the observed decreased ATBV/ACVP ratio.
The possibility remains that the increased right atrial pressure in hypertensives could be due to a reduced compliance of the vascular system. The ATBV/ACVP ratio has been shown to be an adequate index of the effective compliance of the vascular bed in hypertensives. 
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Relationship between the change in stroke volume during expansion and the ATBV/ACVP ratio in the overall population (hypertensives plus normotensive controls). For abbreviations see table 5.
significant fraction of the total compliance, the reduced ATBV/ACVP ratio indicates a disturbance in the pressure-volume relationship of the venous bed. In favor of this interpretation is the finding of a positive correlation between the ratio and peripheral venous compliance ( fig. 4) . Thus, the reduced ATBV/ACVP ratio points to the existence of a reduced systemic venous distensibility in hypertensives, as previously observed in experimental hypertension and in spontaneous hypertension in rats. 2 '
M~27
In a previous report,' we have emphasized the importance of volume factors in the control of CO of hypertensive patients. This role was suggested by the observation of a higher correlation coefficient of the relationship between CO and blood volume in hypertensives than in normotensives. In the present study, the elevated correlation coefficient was related to a steeper slope of the volume-flow curve. Moreover, the steeper slope was explained by the finding of a reduced effective compliance of the vascular bed in hypertension. As shown in figure 5 , the more reduced the compliance, the higher the increase in CO and stroke volume and, consequently, the higher the slope of the relationship between CO and blood volume. The decreased compliance is difficult to explain in hypertension. It could represent a primary or a secondary defect. 18 
'
n Whatever the mechanisms involved, such a result points to the role of venous compliance in the control of CO in hypertensive patients.
